Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, sold RAPP on Oct 7, 2026
Data as of Oct 16
▼ SELL$35.2K1,147 shares at $30.66Abraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.
- Traded
- Oct 7, 2026
- Disclosed
- Oct 8, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RAPP since disclosure
−7.6%
after the sale
Similar stocks (SPY) since disclosure
−1.4%
S&P 500 (SPY)
Change in closing price from Oct 8, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$108Kdisclosed Oct 8 · filed 2 days after the trade